Insulin-Like Growth Factor (Igf) System And Hormonal--Metabolic Profile In Women With Polycystic Ovary Syndrome

AIM of the study was to compare serum levels of IGF-1, IGF-2 and insulin-like growth factor-binding protein 3 (IGFBP-3) among non-obese and obese PCOS women, and to assess their relationship to metabolic and hormonal parameters. METHODS: The study included 64 women diagnosed with PCOS (age 28.9 +/- 5 years); 30 of them with BMI > 27 and 34 with BMI lower than 27. All subjects were examined for parameters of glucose and lipid metabolism, steroid hormones and serum IGF-1, IGF-2 and IGFBP-3 levels. RESULTS: No signifi cant differences in serum IGFBP-3 (p=0.534), IGF-1 (p=0.29) and IGF-2 (p=0.56) between two groups have been detected. IGFBP-3 was in positive correlation with total cholesterol (p=0.026), LDL cholesterol (p=0.03) and triacylglycerols (p=0.022). IGF-1 were negatively correlated with insulin (p=0.022), HOMA IR (p=0.033), triacylglycerols (p=0.0196) and waist circumference (p=0.049). A positive correlation was detected between IGF-1 and HDL cholesterol (p=0.025). No signifi cant relationship was observed between IGF-1 and steroid hormones. CONCLUSION: Serum levels of IGF-1, IGF-2 and IGFBP-3 in obese PCOS women do not differ from those detected in non-obese PCOS women. IGF-1 negatively correlated with metabolic parameters, indicating that lower IGF-1 may represent an important predictor of metabolic syndrome (MS) in PCOS women. All peptides seem to have little effect on ovarian in PCOS 1, 1, Ref. Text in PDF www.elis.sk